Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Keiretsu Capital
AddedFeb 15, 2024
UpdatedJun 28, 2026
Keiretsu Capital

Keiretsu Capital

Operating

Keiretsu Capital: A global venture capital firm investing in IT, healthcare, cleantech, and fintech.

Location
Seattle, WA, US
Founded
2013
Firm
Compare
Portfolio
Fundraising
Employees
Website

Investments

Earthgrid
Earthgrid

Total Raised

$30M

Rounds

6

SeedMay 2023
Buoy
Buoy

Total Raised

$2.6M

Rounds

4

Seed$2.5MMay 2023
BioInteractive Technologies
BioInteractive Technologies

Total Raised

$270k

Rounds

10

Convertible NoteMay 2023
Tend Health
Tend Health

Total Raised

$3.5M

Rounds

4

Convertible NoteApril 2023
Turn Technologies
Turn Technologies

Total Raised

$11M

Rounds

11

SeedApril 2023
Convertible NoteDecember 2022
Galen Robotics
Galen Robotics

Total Raised

$15M

Rounds

3

Convertible NoteApril 2023
NuvOx Pharma
NuvOx Pharma

Total Raised

$19M

Rounds

22

Convertible NoteApril 2023
Kineta
Kineta
Acquired

Total Raised

$98M

Rounds

22

Post Ipo Equity$6MApril 2023
Stracker Solar
Stracker Solar

Total Raised

$940k

Rounds

2

Convertible NoteApril 2023
SpIntellx
SpIntellx

Total Raised

$1.7M

Rounds

9

Convertible NoteFebruary 2023
Volan Technology
Volan Technology

Total Raised

$5.5M

Rounds

5

Seed$1MDecember 2022
DecisionNext
DecisionNext

Total Raised

$9M

Rounds

5

Series ADecember 2022
Yellow Card Financial
Yellow Card Financial

Total Raised

$56.5M

Rounds

5

Series B$40MSeptember 2022
Shyft
Shyft

Total Raised

$31.3M

Rounds

7

Series B$16MSeptember 2022
React Mobile
React Mobile

Total Raised

$10.4M

Rounds

9

Convertible NoteSeptember 2022
Key Travel Concierge
Key Travel Concierge

Total Raised

$18.1M

Rounds

8

Series CJune 2022
Lumoptik
Lumoptik

Total Raised

$900k

Rounds

2

SeedJune 2022
Sonavex
Sonavex

Total Raised

$18M

Rounds

15

Series AMay 2022
Inmedix
Inmedix

Total Raised

$9.3M

Rounds

6

SeedApril 2022
LumiThera
LumiThera

Total Raised

$36.5M

Rounds

9

Debt Financing$5.5MMarch 2022
InfiniteWorld
InfiniteWorld

Rounds

2

Convertible NoteDecember 2021
KitoTech Medical
KitoTech Medical

Total Raised

$15.9M

Rounds

7

Series B$2MDecember 2021
Epilogue Systems
Epilogue Systems

Total Raised

$13M

Rounds

7

Series ANovember 2021
Pathware
Pathware

Total Raised

$17.6M

Rounds

5

Series Unknown$8.1MOctober 2021